Lupin said its American subsidiary has received an approval from the US health regulator to market a generic product used for treatment of skin issues. New Jersey-based Novel Laboratories Inc has received the approval from the US Food and Drug Administration (USFDA) for Fluocinolone Acetonide Topical Oil, Lupin said in a statement.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/VIi7meo
via IFTTT
0 comments:
Post a Comment